A5082199053- Influenza Virus Research Studies
- Bacterial Infections and Vaccines
- Rabies epidemiology and control
- Vector-borne infectious diseases
- Herpesvirus Infections and Treatments
- Advancements in Transdermal Drug Delivery
- Virology and Viral Diseases
Boehringer Ingelheim (United States)
2020
Three groups of approximately eight-week-old beagles were vaccinated once with 1 ml placebo vaccine (oral, n=9), Recombitek® Oral Bordetella n=10) or Nobivac® Intra-Trac3 (intranasal, 0.5 ml/nostril, n=10). Seven days after vaccination, the three challenged virulent bronchiseptica via aerosolisation. Eight nine dogs in group and no developed spontaneous cough two more consecutive (disease case definition). Dogs had a significantly lower incidence disease (P<0.0001) 100 per cent preventable...
Very few studies have evaluated the duration of immunity Bordetella bronchiseptica vaccines in dogs, and to date, no been published on oral canine vaccines. This study was designed determine effectiveness a single dose an B vaccine dogs when challenged 13 months after vaccination.Two groups approximately eight-week-old beagles were vaccinated once with 1 ml placebo (oral, n=17) or Recombitek Oral n=17). Thirteen vaccination, both virulent via aerosolisation.Thirteen 17 group (76.5 per cent)...